Journal of In Silico & In Vitro Pharmacology

Gjumrakch Aliev
President and CEO GALLY” International Biomedical Research Consulting LLC, San Antonio, USA.

Biography

Dr. Gjumrakch Aliev, MD, PhD, President â GALLYâ International Biomedical Research Institute Inc., San Antonio, Texas, USA. He also hold appointment with the University of Atlanta, Atlanta, Georgia, USA as a Professor of Cardiovascular, Neuropathology, Gerontology, Health Science and Healthcare Administration. He received his MD in 1982, from the Baku Medical University (former USSR) with cum laude. Then he accomplished his PhD in Cardiovascular Diseases from the prestigious Russian Academy of the Medical Sciences, Moscow, Russia in 1988 with cum laude. He received postdoctoral training with Professor G. Burnstock in the University College ofthe London. He authored and coauthored more than 500 publications in the fields of neurodegenerative diseases research (Alzheimer disease), as well as cardio and cerebrovascular disease, cancer and electron microscopy. He is an outstanding teacher, scholar, and a renowned scientist in the area of cellular molecular physiology, and cardiovascular, and neurodegeneration-mediated pathologies including Alzheimer disease (AD). He is nationally and internationally reputed in his area. Dr. Alievâ?s accomplishments in the area of biochemistry and cellular biology have tremendous implications for drug design towards CNS Neurological Disorders, AD, cancer, and cerebrovascular and neurodegeneration related pathologies. He is world-renowned expert in electron microscopy. His work has been published in numerous prestigious journals such as Nature Clinical Cardiology, J. Neuroscience, Circulation Research, New England journal of Medicine, Blood, J. Cellular and Molecular Medicine, Atherosclerosis, CNS Neurological Disorders & Drug Targets, international J. Biochemistry and Cell Biology, and many others which reflect his leading role in his research areas. He is currently the Editor in Chiefs for â Central Nervous System Agents in Medicinal Chemistryâ, â Applied Cell Biologyâ, â World Journal of Neuroscienceâ, â Open Journal of Psychiatryâ and â Journal of Aging Scienceâ, Cardiovascular & Hematological Agents in Medicinal Chemistry as well as which by itself shows the voluminous and outstanding work he has accomplished in the area of cellular and molecular biology as well as aged associated clinical sciences. He is one of most cited authors in his fields with high impact factors.

Research Interest

Cell Biology and Functional Morphology of Cell and Tissues: Endothelial cells, Smooth Muscle Cells; Neurons and as well as Glial and Macrophages Cells; Specific characteristics changes of cell morphology in different functional states; particularly atherogenesis, vascular remodeling, hypertension, ischemia/reperfusion, tumor angiogenesis, signal transduction and mitochondria DNA deletion and/or overproliferation during cancer growth, metastases and Alzheimer diseases; Regulation mechanisms of specific nitric oxide synthase (NOS) expression in endothelial and smooth muscle cells and macrophages in vivo and in vitro; Role of NO in the pathogenesis of oxidative stress; Role of Caveolin and its localization in the production of NO in different diseases conditions; Study of therapeutic role of NO-donor and NO suppressors and ET receptor antagonists in different vascular diseases such as atherosclerosis, vascular remodeling, ischemia/reperfusion and tumor angiogenesis; Study of the cellular and subcellular mechanisms of damage of pyramidal neurons and vascular wall cells during the development of Alzheimerâs disease and the future new wave of treatment for these diseases; Design and Monitoring Clinical study: Stress relief and memory training in conjunction with selective natural antioxidants as an alternate method for treatment of age associated mental retardation and depression.